Aiping Lyu

2.4k total citations · 1 hit paper
57 papers, 1.2k citations indexed

About

Aiping Lyu is a scholar working on Molecular Biology, Complementary and alternative medicine and Oncology. According to data from OpenAlex, Aiping Lyu has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 17 papers in Complementary and alternative medicine and 7 papers in Oncology. Recurrent topics in Aiping Lyu's work include Traditional Chinese Medicine Studies (11 papers), Complementary and Alternative Medicine Studies (8 papers) and Clinical practice guidelines implementation (5 papers). Aiping Lyu is often cited by papers focused on Traditional Chinese Medicine Studies (11 papers), Complementary and Alternative Medicine Studies (8 papers) and Clinical practice guidelines implementation (5 papers). Aiping Lyu collaborates with scholars based in Hong Kong, China and Canada. Aiping Lyu's co-authors include Zhaoxiang Bian, Ge Zhang, Wai Ching Lam, Xiangxiang Zeng, Wenxuan Wang, Tingjun Hou, Chengkun Wu, Ningning Wang, Wentao Zhao and Jiacai Yi and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Aiping Lyu

47 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support

2024 349 citations Li Fu, Shaohua Shi et al. Nucleic Acids Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aiping Lyu Hong Kong	17	511	159	125	124	113	57	1.2k
Jiang Ting-liang China	18	563 1.1×	157 1.0×	87 0.7×	87 0.7×	297 2.6×	41	1.4k
Scott W. Mittelstadt United States	23	520 1.0×	161 1.0×	64 0.5×	129 1.0×	68 0.6×	65	1.5k
Ghazi A. Damanhouri Saudi Arabia	24	494 1.0×	73 0.5×	114 0.9×	77 0.6×	104 0.9×	67	1.7k
Pei‐Yi Chen Taiwan	22	493 1.0×	89 0.6×	103 0.8×	42 0.3×	115 1.0×	89	1.3k
Muhammad Rizwan Sweden	9	366 0.7×	69 0.4×	71 0.6×	44 0.4×	110 1.0×	12	938
Tingting Chen China	21	429 0.8×	100 0.6×	83 0.7×	40 0.3×	165 1.5×	63	1.2k
Thakur Uttam Singh India	19	419 0.8×	80 0.5×	42 0.3×	131 1.1×	82 0.7×	66	1.3k
Qiang Zheng China	21	592 1.2×	76 0.5×	56 0.4×	79 0.6×	70 0.6×	45	1.3k
Yu‐Ching Cheng Taiwan	15	238 0.5×	106 0.7×	56 0.4×	110 0.9×	62 0.5×	31	958

Countries citing papers authored by Aiping Lyu

Since Specialization

Citations

This map shows the geographic impact of Aiping Lyu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aiping Lyu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aiping Lyu more than expected).

Fields of papers citing papers by Aiping Lyu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aiping Lyu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aiping Lyu. The network helps show where Aiping Lyu may publish in the future.

Co-authorship network of co-authors of Aiping Lyu

This figure shows the co-authorship network connecting the top 25 collaborators of Aiping Lyu. A scholar is included among the top collaborators of Aiping Lyu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aiping Lyu. Aiping Lyu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Lei, et al.. (2025). Interactions between traditional chinese medicine and gut microbiota in chronic diseases. Pharmacological Research - Modern Chinese Medicine. 16. 100659–100659.

Chen, Qi, et al.. (2025). Regulatory frameworks and evidence requirements for traditional, complementary and integrative medicines; Australia, Canada, China, Republic of Korea, the United States of America and the European Union. Bulletin of the World Health Organization. 103(11). 696–707C.

Huang, Wei‐Chiao, Xiaoli Chen, Zhipeng Meng, et al.. (2025). CD31 regulates metabolic switch in Treg migration attenuates rheumatoid arthritis. Clinical and Translational Medicine. 15(8). e70441–e70441. 1 indexed citations

Luo, Han-Yan, Jing Fang, Caixia Dong, et al.. (2024). Dissecting the anti-obesity components of ginseng: How ginseng polysaccharides and ginsenosides target gut microbiota to suppress high-fat diet-induced obesity. Journal of Advanced Research. 75. 811–828. 7 indexed citations

Wang, Juan, Chung Wah Cheng, Yaochen Wang, et al.. (2024). Evaluation of compliance of CONSORT-CHM formula 2017 in randomized controlled trials of Chinese herbal medicine formulas: protocol of a five-year review. Frontiers in Pharmacology. 15. 1287262–1287262.

Shi, Shaohua, Li Fu, Jiacai Yi, et al.. (2024). ChemFH: an integrated tool for screening frequent false positives in chemical biology and drug discovery. Nucleic Acids Research. 52(W1). W439–W449.

Zhang, Lin, et al.. (2024). Reporting characteristics and quality of randomized controlled trial protocols in traditional Chinese medicine: a cross-sectional study. Frontiers in Pharmacology. 15. 1389808–1389808. 1 indexed citations

Xu, Keyang, Ai Fu, Tao Su, et al.. (2024). Elevated extracellular matrix protein 1 in circulating extracellular vesicles supports breast cancer progression under obesity conditions. Nature Communications. 15(1). 1685–1685. 10 indexed citations

Zhang, Xuan, Jacky C. P. Chan, Nana Wang, et al.. (2023). STandards for Reporting Interventions in Clinical Trials Of Tuina/Massage (STRICTOTM): Extending the CONSORT statement. Journal of Evidence-Based Medicine. 16(1). 68–81. 7 indexed citations

10.

Lyu, Aiping, et al.. (2023). Accurate and interpretable gene expression imputation on scRNA-seq data using IGSimpute. Briefings in Bioinformatics. 24(3). 6 indexed citations

11.

Li, Zhanghao, Chuanxin Zhong, Li Chen, et al.. (2023). The roles of hepatokine and osteokine in liver-bone crosstalk: Advance in basic and clinical aspects. Frontiers in Endocrinology. 14. 1149233–1149233. 11 indexed citations

12.

Zhang, Jialing, et al.. (2023). Prevalence and risk factors of long COVID 6–12 months after infection with the Omicron variant among nonhospitalized patients in Hong Kong. Journal of Medical Virology. 95(6). e28862–e28862. 22 indexed citations

13.

Zhang, Jinfang, Aiping Lyu, & Chao Wang. (2023). The molecular insights of bile acid homeostasis in host diseases. Life Sciences. 330. 121919–121919. 6 indexed citations

14.

Chen, Jiaxing, et al.. (2022). dynDeepDRIM: a dynamic deep learning model to infer direct regulatory interactions using time-course single-cell gene expression data. Briefings in Bioinformatics. 23(6). 16 indexed citations

15.

Zhang, Ge, et al.. (2022). Advanced Glycation End-Product Precursor Methylglyoxal May Lead to Development of Alzheimer’s Disease. Diabetes Metabolic Syndrome and Obesity. Volume 15. 3153–3166. 10 indexed citations

16.

Chen, Jiaxing, Liang Lan, Xin Zhou, et al.. (2021). DeepDRIM: a deep neural network to reconstruct cell-type-specific gene regulatory network using single-cell RNA-seq data. Briefings in Bioinformatics. 22(6). 58 indexed citations

17.

Zhang, Chi, Li Li, Yong Tan, et al.. (2021). Weight changes in hypertensive patients with phlegm-dampness syndrome: an integrated proteomics and metabolomics approach. Chinese Medicine. 16(1). 54–54. 2 indexed citations

18.

Zhong, Linda L. D., Wai Ching Lam, Fang Lü, et al.. (2021). A Comparative Study for License Application Regulations on Proprietary Chinese Medicines in Hong Kong and Canada. Frontiers in Medicine. 8. 617625–617625. 1 indexed citations

19.

Lam, Wai Ching, Aiping Lyu, & Zhaoxiang Bian. (2019). ICD-11: Impact on Traditional Chinese Medicine and World Healthcare Systems. Pharmaceutical Medicine. 33(5). 373–377. 58 indexed citations

20.

Lyu, Aiping. (2006). Correlation Between Heat or Cold Syndrome and Cytokine, and Laboratory Index in Women with Early Rheumatoid Arthritis. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact